NO914250L - Fremgangsmaate for fremstilling av piperazinderivater - Google Patents
Fremgangsmaate for fremstilling av piperazinderivaterInfo
- Publication number
- NO914250L NO914250L NO91914250A NO914250A NO914250L NO 914250 L NO914250 L NO 914250L NO 91914250 A NO91914250 A NO 91914250A NO 914250 A NO914250 A NO 914250A NO 914250 L NO914250 L NO 914250L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- piperazine derivatives
- preparing piperazine
- preparing
- derivatives
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU906953A HU209723B (en) | 1990-10-31 | 1990-10-31 | Process for producing of piperazine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO914250D0 NO914250D0 (no) | 1991-10-30 |
| NO914250L true NO914250L (no) | 1992-05-04 |
Family
ID=10972063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91914250A NO914250L (no) | 1990-10-31 | 1991-10-30 | Fremgangsmaate for fremstilling av piperazinderivater |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0483932A1 (cs) |
| JP (1) | JPH04264078A (cs) |
| KR (1) | KR920008018A (cs) |
| AU (1) | AU8683091A (cs) |
| CA (1) | CA2054544A1 (cs) |
| CS (1) | CS329491A3 (cs) |
| HU (1) | HU209723B (cs) |
| NO (1) | NO914250L (cs) |
| PL (1) | PL292227A1 (cs) |
| PT (1) | PT99368A (cs) |
| ZA (1) | ZA918636B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0585500A1 (en) * | 1992-09-04 | 1994-03-09 | Merrell Dow Pharmaceuticals Inc. | Diaryl piperazineacetamides as antimuscarinic agents |
| US6552023B2 (en) | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
| US6451798B2 (en) | 2000-02-22 | 2002-09-17 | Cv Therapeutics, Inc. | Substituted alkyl piperazine derivatives |
| WO2001062711A2 (en) | 2000-02-22 | 2001-08-30 | Cv Therapeutics, Inc. | Substituted alkylene diamine compounds |
| NZ520782A (en) * | 2000-02-22 | 2004-03-26 | Cv Therapeutics Inc | Substituted piperazine compounds that are partial fatty acid oxidation inhibitors |
| US6677336B2 (en) | 2000-02-22 | 2004-01-13 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| AU2001238590A1 (en) | 2000-02-22 | 2001-09-03 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| KR100797835B1 (ko) * | 2001-08-13 | 2008-01-24 | 주식회사 포스코 | 핀치롤의 이물질 제거장치 |
| NZ541069A (en) | 2003-01-03 | 2008-09-26 | Cv Therapeutics Inc | Piperazine derivatives as fatty acid oxidation inhibitors |
| CA2530376A1 (en) | 2003-06-23 | 2005-01-06 | Cv Therapeutics, Inc. | Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| CA2550257A1 (en) * | 2003-12-18 | 2005-07-07 | Cv Therapeutics, Inc. | 1-akan-2-ol substituted piperazine and piperidine compounds |
| WO2006008753A1 (en) * | 2004-07-19 | 2006-01-26 | Unichem Laboratories Limited | Crystalline and amorphous form of ranolazine and the process for manufacturing them |
| WO2008047388A2 (en) * | 2006-10-20 | 2008-04-24 | Ind-Swift Laboratories Limited | Improved process for the preparation of ranolazine |
| WO2008139492A2 (en) * | 2007-05-15 | 2008-11-20 | Natco Pharma Limited | A process for the preparation of highly pure ranolazine base |
| WO2010029436A2 (en) * | 2008-09-09 | 2010-03-18 | Actavis Group Ptc Ehf | Novel solid state forms of ranolazine salts |
| EP2356097A2 (en) * | 2008-10-15 | 2011-08-17 | Actavis Group PTC ehf. | Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
| WO2010097805A1 (en) | 2009-02-24 | 2010-09-02 | Lupin Limited | A process for the preparation of ranolazine |
| EP3233814A4 (en) | 2015-03-10 | 2018-07-18 | Unichem Laboratories Limited | Novel process for the preparation of ranolazine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB662283A (en) * | 1948-08-02 | 1951-12-05 | Rhone Poulenc Sa | Improvements in or relating to piperazine compounds |
| US4567264A (en) * | 1983-05-18 | 1986-01-28 | Syntex (U.S.A.) Inc. | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
-
1990
- 1990-10-31 HU HU906953A patent/HU209723B/hu not_active IP Right Cessation
-
1991
- 1991-10-29 PT PT99368A patent/PT99368A/pt not_active Application Discontinuation
- 1991-10-30 CA CA002054544A patent/CA2054544A1/en not_active Abandoned
- 1991-10-30 KR KR1019910019180A patent/KR920008018A/ko not_active Withdrawn
- 1991-10-30 JP JP3285053A patent/JPH04264078A/ja active Pending
- 1991-10-30 NO NO91914250A patent/NO914250L/no unknown
- 1991-10-30 ZA ZA918636A patent/ZA918636B/xx unknown
- 1991-10-30 PL PL29222791A patent/PL292227A1/xx unknown
- 1991-10-30 CS CS913294A patent/CS329491A3/cs unknown
- 1991-10-30 AU AU86830/91A patent/AU8683091A/en not_active Abandoned
- 1991-10-31 EP EP91202836A patent/EP0483932A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04264078A (ja) | 1992-09-18 |
| PT99368A (pt) | 1992-09-30 |
| PL292227A1 (en) | 1992-06-26 |
| NO914250D0 (no) | 1991-10-30 |
| KR920008018A (ko) | 1992-05-27 |
| CS329491A3 (en) | 1992-05-13 |
| HUT62278A (en) | 1993-04-28 |
| AU8683091A (en) | 1992-05-07 |
| ZA918636B (en) | 1992-08-26 |
| EP0483932A1 (en) | 1992-05-06 |
| HU906953D0 (en) | 1991-05-28 |
| CA2054544A1 (en) | 1992-05-01 |
| HU209723B (en) | 1994-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI914163A7 (fi) | Heterosykliset johdannaiset | |
| NO913234D0 (no) | Fremgangsmaate for fremstilling av pyrazolderivater. | |
| FI930799L (fi) | Piperazinylderivat | |
| NO914250D0 (no) | Fremgangsmaate for fremstilling av piperazinderivater | |
| ATE144765T1 (de) | Hiv-hemmende benzenacetamidderivate | |
| NO913745D0 (no) | Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater | |
| NO920965L (no) | Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer | |
| NO924028L (no) | Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater | |
| NO901070L (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
| NO914056D0 (no) | Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat | |
| FI921319A7 (fi) | Menetelmä kinoliinijohdannaisten valmistamiseksi | |
| NO901071L (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
| DK91890D0 (da) | Piperazin-derivater | |
| GB2248837B (en) | Piperazine derivatives | |
| NO914053D0 (no) | Fremgangsmaate for fremstilling av 8-klorokinolonderivater | |
| NO912980D0 (no) | Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater | |
| NO925007D0 (no) | Fremgangsmaate for fremstilling av benzofuranylimidazolderivater | |
| NO893713D0 (no) | Fremgangsmaate for fremstilling av benzoksazolon-derivater. | |
| NO914985D0 (no) | Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater | |
| FI911633A7 (fi) | Menetelmä alkaanisulfoanilidijohdosten valmistamiseksi | |
| NO914452L (no) | Fremgangsmaate for fremstilling av isokinolinderivater | |
| FI913656A7 (fi) | Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi | |
| NO901812D0 (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
| NO901069D0 (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
| NO923481D0 (no) | Fremgangsmaate for fremstilling av 1-hydroksyalkyl-5-nitroimidazol |